Format

Send to

Choose Destination
See comment in PubMed Commons below
Neuropsychobiology. 2007;55(1):47-51. Epub 2007 Jun 8.

No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.

Author information

1
Department of Psychiatry, Korea University College of Medicine, Seoul, South Korea.

Abstract

Tardive dyskinesia (TD) is a long-term adverse effect of antipsychotics. We evaluated whether a candidate functional polymorphism of the dopamine D4 receptor (DRD4) gene is associated with drug-induced TD in 209 Korean schizophrenic patients with TD (n = 83) and without TD (n = 126) who were matched for antipsychotic drug exposure and other relevant variables. There was no significant association of the genotype and allele frequencies determined by the -521 C/T SNP of DRD4 between TD and non-TD patients. In addition, there was no significant difference in terms of total Abnormal Involuntary Movement Scale scores among the 3 genotype groups. Within the limitations imposed by the size of the clinical sample, these findings suggest that the DRD4 -521 C/T SNP does not contribute significantly to the risk for TD.

PMID:
17556853
DOI:
10.1159/000103576
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Support Center